TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Download Report PDF Instantly
Report overview
The global Colorectal Cancer Screening market was valued at US$ 662.8 million in 2022 and is projected to reach US$ 782.1 million by 2029, at a CAGR of 2.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Colorectal Cancer Screening market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Colorectal Cancer Screening market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Colorectal Cancer Screening market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Colorectal cancer(CRC) is known asbowel cancerand colon cancer. It is the development ofcancerfrom thecolon or rectum. Screening for colorectal cancer can help prevent and treat the disease.
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Screening. This report contains market size and forecasts of Colorectal Cancer Screening in global, including the following market information:
Global Colorectal Cancer Screening Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Stool-based Tests Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Colorectal Cancer Screening include Abbott, Clinical Genomics Technologies, Epigenomics Inc, Exact Sciences, Roche, Hemosure Inc, Novigenix SA, Quidel and Siemens, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Colorectal Cancer Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Chapter 1: Introduces the definition of Colorectal Cancer Screening, market overview.
Chapter 2: Global Colorectal Cancer Screening market size in revenue.
Chapter 3: Detailed analysis of Colorectal Cancer Screening company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Colorectal Cancer Screening in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
